Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4130-4138

  Badia, E ^a   Duchesne, M J ^a   Semlali, A ^a   Fuentes, M ^a   Giamarchi, C ^a   Richard Foy, H ^a   Nicolas, J C ^a   Pons, M ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DNA; ESTROGEN; HYDROXYTAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CHROMATIN STRUCTURE; DNA MODIFICATION; GENE EXPRESSION; GENE INACTIVATION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL DIVISION; CHROMATIN; DEOXYRIBONUCLEASE I; DNA METHYLATION; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, HORMONE-DEPENDENT; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; PROTEINS; RECEPTORS, ESTRADIOL; RECEPTORS, PROGESTERONE; TAMOXIFEN; THYMIDINE KINASE; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; VITELLOGENINS; XENOPUS;

EID: 0033870250     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Tamoxifen: The herald of a new era of preventive therapeutics (editorial, comment)
2. The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth
3. Abnormal estrogen receptor in clinical breast cancer
4. Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: Involvement of the estrogen receptor
5. Hypothesis. Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals
6. Tamoxifen resistant breast cancer: Coregulators determine the direction of transcription by antagonist-occupied steroid receptors
7. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
8. Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line
9. Rapid tamoxifen-induced inactivation of an estrogenic response is accompanied by a localized epigenetic modification but not mutations
10. A new cellular model of response to estrogens: A bioluminescent test to characterize (anti) estrogen molecules
11. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness (in process citation)
12. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol
13. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer
14. An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells
15. A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro
16. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction
17. Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: II. Receptor-antiglucocorticoid complexes do not interact productively with mouse mammary tumor virus long terminal repeat chromatin
18. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
19. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation
20. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B
21. MVLN cells: A bioluminescent MCF-7 derived cell line to study the modulation of estrogenic activity
22. The metabolism and genotoxicity of tamoxifen
23. Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats
24. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients
25. Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: Analysis by quantitative dual parameter flow cytometry
26. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms
27. Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells
28. The formation and function of DNase I hypersensitive sites in the process of gene activation
29. Nucleic acid sequence and DNase hypersensitive sites of the 5' region of the mouse progesterone receptor gene
30. Chromatin-silencing mechanisms in Drosophila maintain patterns of gene expression
31. Silencing speaks up
32. Spreading the silence: Epigenetic transcriptional regulation during Drosophila development
33. Molecular model for telomeric heterochromatin in yeast
34. The vagaries of variegating transgenes
35. The formation of DNA methylation patterns and the silencing of genes
36. How does DNA methylation repress transcription?
37. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression (in process citation)
38. Differential underacetylation of histones H2A, H3 and H4 on the inactive X chromosome in human female cells
39. X-inactivation and histone H4 acetylation in embryonic stem cells
40. The histone deacetylase RPD3 counteracts genoraic silencing in Drosophila and yeast
41. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression
42. Steroid receptor induction of gene transcription: A two-step model
43. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin
44. Butyrate and related inhibitors of histone deacetylation block the induction of egg white genes by steroid hormones
45. Increased steroid responsiveness during sodium butyrate-induced 'differentiation' of HeLa S3 cells
46. Methylation-induced repression-belts, braces, and chromatin
47. Regulating genes by packaging domains: Bits of heterochromatin in euchromatin?
48. Polycombing the genome: PcG, trxG, and chromatin silencing
49. PcG complexes and chromatin silencing
50. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors
51. TIF1 alpha: A chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors?
52. KRAB zinc finger proteins and nuclear receptors: A possible cross-talk (editorial, in process citation)
53. Two distinct nuclear receptor interaction domains in NSD1, a novel SET domain protein that exhibits characteristics of both corepressors and coactivators